Esperion Therapeutics | ESPR - Employees Total Number

Stock Price
2.81
Daily Change
0.19 7.06%
Monthly
-16.52%
Yearly
72.09%
Q1 Forecast
2.47

Esperion Therapeutics reported 240 in Employees for its fiscal year ending in December of 2023.





Employees Change Date
AbbVie 55K 5K Dec/2024
Alnylam Pharmaceuticals 2.23K 130 Dec/2024
Alterity Therapeutics Limited AUD 12 1 Jun/2022
Amarin 275 90 Dec/2023
Amgen 28K 1.3K Dec/2024
Biogen 7.6K 35 Dec/2024
BioMarin Pharmaceutical 3.04K 361 Dec/2024
Cipla 30.31K 2.55K Dec/2025
CSL USD 32.06K 1.67K Dec/2025
Cytokinetics 498 75 Dec/2024
Daiichi Sankyo 19.76K 1.04K Dec/2025
Eli Lilly 47K 4K Dec/2024
Esperion Therapeutics 240 41 Dec/2023
Geron 229 88 Dec/2024
Grifols EUR 23.83K 89 Dec/2024
Halozyme Therapeutics 350 23 Dec/2024
Heron Therapeutics 126 77 Dec/2023
Ionis Pharmaceuticals 1.07K 142 Dec/2024
Merck 75K 3K Dec/2024
Minerva Neurosciences 9 0 Dec/2023
Moderna 5.8K 200 Dec/2024
Nektar Therapeutics 137 79 Dec/2023
Pfizer 81K 7K Dec/2024
PTC Therapeutics 939 49 Dec/2024
Puma Biotechnology 185 7 Dec/2023
Regeneron Pharmaceuticals 13.45K 1.6K Dec/2023
Sanofi 84.59K 3.41K Dec/2024
Sarepta Therapeutics 1.37K 58 Dec/2024
United Therapeutics 1.3K 137 Dec/2024
Vanda Pharmaceuticals 203 87 Dec/2023